Valion Bio earnings were -$8.9M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest VBIO earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$2.8M, up 9.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, VBIO reported annual earnings of -$8.9M, with 57% growth. The next VBIO earnings date is Aug 13, 2026.
Valion Bio (NASDAQ: VBIO) reported Q4 2025 earnings per share (EPS) of -$1.35, up 7.53% year over year. Total VBIO earnings for the quarter were -$2.85 million. In the same quarter last year, Valion Bio's earnings per share (EPS) was -$1.46.
The next VBIO earnings date is Aug 13, 2026. Add VBIO to your watchlist to be reminded of Valion Bio's next earnings date.
What was VBIO's earnings growth in the past year?
As of Valion Bio's earnings date in Q3 2026, Valion Bio's earnings has grown year over year. VBIO earnings in the past year totalled -$8.88 million.
Is Valion Bio profitable or losing money?
As of the last Valion Bio earnings report, Valion Bio is currently losing money. Valion Bio's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$8.88 million, a 56.99% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.